congratulations, Matthew!

[UPDATE 8/20/17:  Read the paper here.] Congratulations to lab alumnist Matthew on the acceptance of his manuscript acceptance by PLoS One.  This study conducted at cc-TDI explored 2 potential drugs for rhabdomyosarcoma.  One drug targeted EphB4, and the other drug targeted EphrinB2.   Co-authors include cc-TDI lab member Megan, lab alumni Zia, Matthew Sv., and Michael. Collaborators included Atiya Mansoor (OHSU); Pali Kaur, Carol Bult, Sunny Xiang and Jim Keck (JAX); Martin Goros and Joel Michalek (UTHSCSA); and Valery Krasnoperov and Parkash Gill (Vasgene Therapeutics).    This study was sponsored by the Thumbs Up for Lane Goodwin Foundation, Live Like Bella Foundation, and the Alex’s Lemonade Stand Foundation.      

Share this post
Share on facebook
Share on google
Share on twitter
Share on linkedin